TrialEuropean journal of cancer (Oxford, England : 1990)2023

Health-Related Quality of Life in Patients With Advanced Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab or Treatment of Physician's Choice.

Domenica Lorusso et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.